Biopreservation Market Report Global Forecast By Product (Equipment, Media, Laboratory Information Management System (LIMS)), Application (Regenerative Medicine, Biobanking, Drug Discovery), Countries and Company Analysis (2025-2033)

Driving Forces of Biopreservation Market 

Growing Interest in Biobanking 

The worldwide market is significantly impacted by the rising need for biobanking. Biobanks are repositories where a variety of biological samples—such as blood, tissues, cells, DNA, and other biomaterials—are kept for use in research and diagnosis. These methods are essential for preserving the samples' viability, integrity, and functionality as well as for guaranteeing their long-term preservation and use. The global biobanks market is being impacted by the increasing demand for extensive population-based studies, clinical trials, and research initiatives that necessitate the availability of a wide range of biological samples that have been conserved. Furthermore, biobanks are more important than ever since they offer a comprehensive collection of samples that can be utilized for genomic testing, biomarker identification, and the creation of customized treatments. This is because biobanks are essential to precision medicine and personalized healthcare.

Continual Innovations in Regenerative Medicine 

Innovations in regenerative medicine have a big impact on the world market. Since regenerative medicine uses novel techniques such as tissue engineering and cell-based therapies to replace or restore damaged tissues or organs, biopreservation is essential to the field's success as it maintains the viability and functionality of cells, tissues, and engineered constructs. Furthermore, during storage and transit, these methods are crucial for preserving the viability and potency of stem cells. Stem cells are frequently preserved via cryopreservation techniques including vitrification and freezing in order to preserve them for use in therapy or research in the future. The market has grown as a result of improvements in cryoprotectants and stem cell preservation techniques that have improved the survivability and post-thaw functionality of stem cells.

North America Biopreservation Market 

North America's established healthcare infrastructure, which includes cutting-edge medical research institutes, pharmaceutical businesses, and biotechnology startups, allowed it to have the largest market share. In order to support their clinical applications, drug discovery, and research, these organizations significantly increase the need for these technologies. 

Furthermore, there is a strong network of biobanks in North America, which includes commercial biobanks, government-funded programs, and academic biorepositories. Biobanks are important users of these technologies because they gather and preserve a variety of biological samples for use in research and medical applications. North American biobanks have created standardized procedures and well-built infrastructure, which helps explain the region's market supremacy.

United States Biopreservation Market

The demand for efficient storage methods for biological samples, tissues, and organs is driving a notable expansion in the biopreservation market in the United States. Biopreservation is the process of preserving biological materials—which are essential for study, diagnosis, and transplantation—by using natural preservatives and carefully regulated low temperatures. 

The effectiveness of biopreservation is being increased by developments in cryopreservation and biotechnology, enabling longer storage times and better sample quality. Growth in the market is also being aided by the increasing focus on personalized treatment and the prevalence of chronic diseases, as more research institutions and biobanks need trustworthy preservation techniques. This market is further supported by investments in healthcare infrastructure and regulatory assistance. The market for biopreservation in the United States is expected to develop in the future due to advancements in technology and rising healthcare needs.

Canada Biopreservation Market

The requirement for reliable biological material storage solutions, such as those for cells, tissues, and organs, is anticipated to drive the Canadian biopreservation market's growth. Technological developments in cryopreservation and rising investments in research centers and biobanks are important drivers of growth. The demand for efficient biopreservation techniques is being further fueled by the increasing focus on regenerative medicines and customized medicine.

Furthermore, there is a growing demand for preserved biological samples due to the necessity for organ transplants and the increased prevalence of chronic diseases. Future developments point to a move toward automation and better monitoring systems to increase the effectiveness of preservation. Furthermore, it is anticipated that growing partnerships between academic institutions and healthcare firms would promote innovation in biopreservation methods. 

Government funding further plays a significant role in the expansion of the biopreservation sector in Canada. Healthcare innovation and biotechnology are being advanced by a number of projects and financing sources. For instance, to support stem cell and regenerative medicine research, the Canadian government invested USD 45 million in the current year over the following three years to the Stem Cell Network. It is projected that these expenditures will increase the region's demand for and utility with biopreservation, driving market growth during the projection period.

Global Biopreservation Company Analysis 

The key players in biopreservation industry are Thermo Fisher Scientific Inc., Cryport, Inc., Eppendorf AG, BioLife Solutions Inc, Azenta Inc, Merck KGaA, Qiagen NV and Chart Industries, Inc.

Global Biopreservation Company News 

June 2023- To increase the size of its CRF product line, BioLife Solutions, Inc. unveiled a new, large-capacity controlled-rate freezer (CRF). With the use of this new product, the business will be able to assist its commercial-scale production, autologous and allogeneic CGT customers, and meet critical customer needs for high-volume cell treatments. 

January 2023- The Binding Site Group, a global leader in specialty diagnostics, and Thermo Fisher Scientific Inc. completed their mergers and acquisition (M&A) agreement. The goal of Thermo Fisher Scientific Inc.'s M&A was to expand its current specialty diagnostics portfolio and add cutting-edge multiple myeloma diagnostics and monitoring. 

October 2022- Azenta, Inc. procured B Medical Systems S.á r.l. and its affiliates, a supplier of transportation and temperature-controlled storage solutions that facilitate the global distribution of life-saving medical interventions. 

July 2022- In Chennai, India, Cellutions BioStorage, a research-to-launch cryopreservation bank, was opened. Full-service biomaterial storage and logistics company Cellutions BioStorage works with biopharmaceutical companies who want to outsource supply chain management for every stage of a product's life cycle. The newly completed facility boasts first-rate infrastructure and is 25,000 square feet in size.

Product– Market breakup in 3 viewpoints:

1. Equipment
2. Media
3. Laboratory Information Management System (LIMS)

Application– Market breakup in 3 viewpoints:

1. Regenerative Medicine
2. Biobanking
3. Drug Discovery

Countries– Market breakup in 25 viewpoints:

1.  North America

1.1    United States

1.2    Canada

2.  Europe

2.1    France       

2.2    Germany  

2.3    Italy            

2.4    Spain          

2.5    United Kingdom    

2.6    Belgium     

2.7    Netherland

2.8    Turkey

3.  Asia Pacific

3.1    China          

3.2    Japan         

3.3    India           

3.4    Australia   

3.5    South Korea            

3.6    Thailand    

3.7   Malaysia    

3.8   Indonesia  

3.9    New Zealand

4.  Latin America

4.1    Brazil

4.2    Mexico

4.3    Argentina

5.  Middle East & Africa

5.1    South Africa

5.2    Saudi Arabia

5.3   UAE

All the key players have been covered from 4 Viewpoints:

• Business Overview
• Key Persons
• Recent Development & Strategies
• Financial Insights

Key Players Analysis: 

• Thermo Fisher Scientific Inc.
• Cryport, Inc.
• Eppendorf AG
• BioLife Solutions Inc
• Azenta Inc
• Merck KGaA
• Qiagen NV
• Chart Industries, Inc.